Multiresistant CTX-M-15 ESBL-producing Escherichia coli in southern Sweden: Description of an outbreak

被引:24
作者
Alsterlund, Rolf [1 ]
Carlsson, Barbro [2 ]
Gezelius, Lena [3 ]
Haeggman, Sara [3 ]
Olsson-Liljequist, Barbro [3 ]
机构
[1] Cent Hosp Kristianstad, Dept Infect Dis, SE-29185 Kristianstad, Sweden
[2] Cent Hosp Kristianstad, Dept Clin Microbiol, SE-29185 Kristianstad, Sweden
[3] Swedish Inst Infect Dis Control, Dept Bacteriol, Solna, Sweden
关键词
SPECTRUM BETA-LACTAMASES; KLEBSIELLA-PNEUMONIAE; SPREAD; IDENTIFICATION; RESISTANT; CARE;
D O I
10.1080/00365540902896079
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
An outbreak caused by a multiresistant Escherichia coli producing CTX-M-15 ESBL occurred during autumn 2005 and spring 2006 in Kristianstad, a town in southern Sweden. The outbreak comprised 27 cases and was related to an infectious diseases ward and a neighbouring long-term care facility. Our primary objective was to investigate the epidemiology in order to control the outbreak. In addition, we studied the time of carriage of multiresistant ESBL-producing Escherichia coli by follow-up samples and measured the frequency of carriage of ESBL-producing bacteria in the patient population admitted to the infectious diseases ward during autumn 2006. The outbreak described is one of the first caused by ESBL-producing Escherichia coli in Sweden. The source of the outbreak was not found. Infection control measures were reinforced in the outbreak situation, and epidemiological and microbiological methods, including PFGE typing, were used for analysis. The carriage time of multiresistant Escherichia coli was longer in several of the affected patients than has previously been reported. The longest carriage time to date is 33 months. This demonstrates the risk for new outbreaks unless strict infection control measures are implemented. Among the patients admitted to the ward during autumn 2006, 2.5% carried ESBL-producing enterobacteria.
引用
收藏
页码:410 / 415
页数:6
相关论文
共 24 条
[1]   Duration of stool colonization in patients infected with extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae [J].
Apisarnthanarak, Anucha ;
Bailey, Thomas C. ;
Fraser, Victoria J. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (08) :1322-1323
[2]  
Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1
[3]   Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes [J].
Bonnet, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :1-14
[4]   Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada [J].
Boyd, DA ;
Tyler, S ;
Christianson, S ;
McGeer, A ;
Muller, MP ;
Willey, BM ;
Bryce, E ;
Gardam, M ;
Nordmann, P ;
Mulvey, MR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) :3758-3764
[5]   Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat [J].
Bradford, PA .
CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) :933-951
[6]   Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe [J].
Canton, R. ;
Novais, A. ;
Valverde, A. ;
Machado, E. ;
Peixe, L. ;
Baquero, F. ;
Coque, T. M. .
CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 :144-153
[7]  
*EARSS MAN TEAM ME, 2007, ANN REP 2006 EARSS M
[8]  
ERNTELL M, 18 ECCMID 2008 BARC
[9]   Molecular epidemiological analysis of Escherichia coli isolates producing extended-spectrum β-lactamases for identification of nosocomial outbreaks in Stockholm, Sweden [J].
Fang, H ;
Lundberg, C ;
Olsson-Liljequist, B ;
Hedin, G ;
Lindbäck, E ;
Rosenberg, Å ;
Struwe, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (12) :5917-5920
[10]   First description of an oxyimino-cephalosporin-resistant, ESBL-carrying Escherichia coli isolated from meat sold in Denmark [J].
Jensen, LB ;
Hasman, H ;
Agerso, Y ;
Emborg, HD ;
Aarestrup, FM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (04) :793-794